{"schema_version":"secwatch.filing_event.v1","accession":"0001860742-24-000007","form_type":"8-K","ticker":"BLCO","cik":"0001860742","company_name":"Bausch & Lomb Corp","filed_at":"2024-05-01T23:59:59+00:00","discovered_at":"2026-05-14T18:03:20.944732+00:00","generated_at":"2026-06-03T03:15:45.051257+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Bausch + Lomb Q1 revenue $1.099B (+18% YoY); raises FY constant-currency growth guidance","bullets":["GAAP net loss attributable widened to $167M from $90M; adjusted EBITDA rose to $180M from $141M.","Vision Care revenue $635M (+8% reported, +11% constant currency); Surgical $197M (+8%); Pharmaceuticals $267M (+66% on XIIDRA/MIEBO).","Raises FY constant-currency revenue growth guidance to 13-15% from 12-14%; revenue range now $4.600-$4.700B.","Adjusted EPS (non-GAAP) $0.07 vs $0.10; GAAP EPS ($0.48) vs ($0.26).","Cash from operations $41M vs use of $56M in Q1 2023; foreign-exchange headwind estimated at $90M for FY."],"urls":{"canonical":"https://secwatch.observer/filing/0001860742-24-000007","json":"https://secwatch.observer/filing/0001860742-24-000007.json","markdown":"https://secwatch.observer/filing/0001860742-24-000007.md","text":"https://secwatch.observer/filing/0001860742-24-000007.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1860742/000186074224000007/0001860742-24-000007-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1860742/000186074224000007/blco-20240501.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-03T03:15:45.051257+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"2f20904e7271c17aef7a0c94fdc8347c64110890","claim":"Bausch & Lomb Corp reported the quarter ended March 31, 2024 results: revenue $1.099 billion, net income $167 million, EPS ($0.48). Guidance raised.","evidence_excerpt":"statement or other document pursuant to the Securities Act of 1933, as amended. --- EX-99.1 (EX-99.1) --- Bausch + Lomb Announces First-Quarter 2024 Results • Revenue of $1.099 Billion • GAAP Net Loss Attributable to Bausch + Lomb Corporation of $167 Million • Adjusted EBITDA (non-GAAP) 1 of $180 Million • Revenue Grew 18% as Reported and 20% on a Constant","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1860742/000186074224000007/0001860742-24-000007-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the quarter ended March 31, 2024"},{"label":"Revenue","value":"$1.099 billion"},{"label":"Net income","value":"$167 million"},{"label":"EPS","value":"($0.48)"},{"label":"Guidance","value":"raised"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}